Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes.

Thomas MC, Moran J, Forsblom C, Harjutsalo V, Thorn L, Ahola A, Wadén J, Tolonen N, Saraheimo M, Gordin D, Groop PH; FinnDiane Study Group.

Diabetes Care. 2011 Apr;34(4):861-6. doi: 10.2337/dc10-1722. Epub 2011 Feb 9.

2.

Dietary salt intake and mortality in patients with type 2 diabetes.

Ekinci EI, Clarke S, Thomas MC, Moran JL, Cheong K, MacIsaac RJ, Jerums G.

Diabetes Care. 2011 Mar;34(3):703-9. doi: 10.2337/dc10-1723. Epub 2011 Feb 2.

3.

Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease.

Agarwal R, Bunaye Z, Bekele DM, Light RP.

Am J Nephrol. 2008;28(4):569-75. doi: 10.1159/000115291. Epub 2008 Feb 1.

PMID:
18239383
4.

Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.

Packham DK, Alves TP, Dwyer JP, Atkins R, de Zeeuw D, Cooper M, Shahinfar S, Lewis JB, Lambers Heerspink HJ.

Am J Kidney Dis. 2012 Jan;59(1):75-83. doi: 10.1053/j.ajkd.2011.09.017. Epub 2011 Nov 3.

PMID:
22051245
5.

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.

Forsblom C, Harjutsalo V, Thorn LM, Wadén J, Tolonen N, Saraheimo M, Gordin D, Moran JL, Thomas MC, Groop PH; FinnDiane Study Group.

J Am Soc Nephrol. 2011 Mar;22(3):537-44. doi: 10.1681/ASN.2010020194. Epub 2011 Feb 18.

6.

Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Rosolowsky ET, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS.

J Am Soc Nephrol. 2011 Mar;22(3):545-53. doi: 10.1681/ASN.2010040354. Epub 2011 Feb 25.

7.

Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.

Forsblom C, Moran J, Harjutsalo V, Loughman T, Wadén J, Tolonen N, Thorn L, Saraheimo M, Gordin D, Groop PH, Thomas MC; FinnDiane Study Group.

Diabetes Care. 2014 Aug;37(8):2334-42. doi: 10.2337/dc14-0225. Epub 2014 May 30.

PMID:
24879837
8.

Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes: a 10-year prospective study.

Bruno G, Biggeri A, Merletti F, Bargero G, Ferrero S, Pagano G, Perin PC.

Diabetes Care. 2003 Aug;26(8):2353-8.

PMID:
12882861
9.
10.

End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry.

Yang XL, So WY, Kong AP, Clarke P, Ho CS, Lam CW, Ng MH, Lyu RR, Yin DD, Chow CC, Cockram CS, Tong PC, Chan JC.

Diabetologia. 2006 Oct;49(10):2299-308. Epub 2006 Aug 30.

PMID:
16944095
11.

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury.

Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G.

Am J Kidney Dis. 2000 Jun;35(6):1155-65.

PMID:
10845831
12.

Association between glycosylated hemoglobin level and 16-year incidence of chronic kidney disease in type 1 diabetes.

Shankar A, Klein R, Klein BE, Moss SE.

Exp Clin Endocrinol Diabetes. 2007 Mar;115(3):203-6.

PMID:
17427112
13.

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.

14.

Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.

Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane Study Group.

Diabetes Care. 2008 Jun;31(6):1165-9. doi: 10.2337/dc07-2306. Epub 2008 Mar 17.

PMID:
18346990
15.

Haptoglobin genotype and renal function decline in type 1 diabetes.

Costacou T, Ferrell RE, Ellis D, Orchard TJ.

Diabetes. 2009 Dec;58(12):2904-9. doi: 10.2337/db09-0874. Epub 2009 Aug 31.

16.

Progression of diabetic nephropathy, risk of end-stage renal disease and mortality in patients with type-1 diabetes.

Bentata Y, Haddiya I, Latrech H, Serraj K, Abouqal R.

Saudi J Kidney Dis Transpl. 2013 Mar;24(2):392-402.

17.

Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.

Rossing K, Christensen PK, Hovind P, Parving HH.

Diabetologia. 2005 Nov;48(11):2241-7. Epub 2005 Sep 17.

PMID:
16170513
18.
19.

Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.

Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA.

Am J Kidney Dis. 2011 Nov;58(5):717-28. doi: 10.1053/j.ajkd.2011.05.020. Epub 2011 Aug 5.

PMID:
21820220
20.

Elderly patients with chronic kidney disease: outcomes after 5 years of follow-up.

Heras M, Fernández-Reyes MJ, Sánchez R, Guerrero MT, Molina A, Rodríguez MA, Alvarez-Ude F.

Nefrologia. 2012 May 14;32(3):300-5. doi: 10.3265/Nefrologia.pre2012.Jan.10994. Epub 2012 Feb 28. English, Spanish.

Items per page

Supplemental Content

Write to the Help Desk